ZARXIO
Drug
Sandoz Inc.
Total Payments
$62,452
Transactions
319
Doctors
159
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $203.90 | 9 | 9 |
| 2022 | $295.04 | 13 | 13 |
| 2021 | $16,283 | 16 | 16 |
| 2020 | $519.28 | 29 | 28 |
| 2019 | $9,403 | 52 | 36 |
| 2018 | $29,647 | 62 | 43 |
| 2017 | $6,101 | 138 | 89 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $41,810 | 2 | 66.9% |
| Consulting Fee | $8,646 | 1 | 13.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,117 | 3 | 11.4% |
| Food and Beverage | $4,879 | 313 | 7.8% |
Payments by Type
Research
$41,810
2 transactions
General
$20,642
317 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| YALE NEW HAVEN HEOR STUDY | Sandoz Inc. | $25,810 | 0 |
| G-CSF UTILIZATION AND CLINICAL OUTCOMES AND HEALTH CARE RESOURCE UTILIZATION ASSOCIATED WITH G-CSF TREATMENT IN PATIENTS WITH BREAST CANCER RECEIVING CHEMOTHERAPY IN A COMMUNITY ONCOLOGY SETTING | Sandoz Inc. | $16,000 | 1 |
Top Doctors Receiving Payments for ZARXIO — Page 2
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Hematology & Oncology | New Albany, IN | $59.46 | 5 |
| , MD | Hematology & Oncology | New Albany, IN | $59.46 | 5 |
| , MD | Hematology & Oncology | New Albany, IN | $59.46 | 5 |
| , M.D | Hematology & Oncology | New Albany, IN | $59.46 | 5 |
| , MD | Hematology & Oncology | The Woodlands, TX | $57.92 | 3 |
| , MD | Hematology & Oncology | Kingwood, TX | $57.92 | 3 |
| , MD | Hematology & Oncology | New Braunfels, TX | $56.71 | 4 |
| , MD | Hematology | San Antonio, TX | $54.72 | 4 |
| , M.D | Medical Oncology | San Antonio, TX | $54.39 | 3 |
| , M.D | Hematology & Oncology | Indianapolis, IN | $52.37 | 4 |
| , MD | Gynecologic Oncology | Miami, FL | $52.35 | 3 |
| , M.D., PH.D | Medical Oncology | Carmel, IN | $51.95 | 4 |
| , M.D | Hematology & Oncology | Terre Haute, IN | $49.46 | 4 |
| , MD | Hematology & Oncology | Lancaster, PA | $48.79 | 2 |
| , M.D | Medical Oncology | Sun City, AZ | $44.23 | 3 |
| , MD | Hematology & Oncology | San Antonio, TX | $43.86 | 3 |
| , M.D | Hematology & Oncology | Harlingen, TX | $42.49 | 3 |
| , M.D., PH.D | Hematology & Oncology | Tukwila, WA | $42.27 | 2 |
| , M.D | Hematology & Oncology | Greenbelt, MD | $42.14 | 2 |
| , M.D | Medical Oncology | Crown Point, IN | $40.52 | 3 |
| , MD | Hematology & Oncology | Crown Point, IN | $40.52 | 3 |
| , MD | Hematology & Oncology | San Antonio, TX | $40.14 | 3 |
| , MD | Medical Oncology | Austin, TX | $39.49 | 2 |
| , MD | Hematology & Oncology | The Woodlands, TX | $39.28 | 2 |
| , MD | Hematology & Oncology | Tomball, TX | $36.30 | 2 |
Ad
Manufacturing Companies
- Sandoz Inc. $62,452
Product Information
- Type Drug
- Total Payments $62,452
- Total Doctors 159
- Transactions 319
About ZARXIO
ZARXIO is a drug associated with $62,452 in payments to 159 healthcare providers, recorded across 319 transactions in the CMS Open Payments database. The primary manufacturer is Sandoz Inc..
Payment data is available from 2017 to 2024. In 2024, $203.90 was paid across 9 transactions to 9 doctors.
The most common payment nature for ZARXIO is "Unspecified" ($41,810, 66.9% of total).
ZARXIO is associated with 2 research studies, including "YALE NEW HAVEN HEOR STUDY" ($25,810).